Rani Therapeutics still has not met Nasdaq's $1-per-share closing-price rule. Nasdaq gave it another 180 days, but the listing problem remains and the company says success is not assured.
The extra time lets Rani's shares keep trading on Nasdaq for now. Rani still needs a closing price of at least $1 for 10 business days, and the filing says success is not assured.
Follow Rani Therapeutics Holdings, Inc. (RANI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for RANI